BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 1 hit Enz. Inhib. hit(s) with Target = 'Pro-glucagon' and Ligand = 'BDBM100812'   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Pro-glucagon


(Homo sapiens (Human))
BDBM100812
PNG
(US8507533, 119)
Show SMILES OC(=O)CCNC(=O)c1ccc(cc1)C(Oc1ccc(cc1)-n1cc2ccccc2n1)C1CCCC1
Show InChI InChI=1S/C29H29N3O4/c33-27(34)17-18-30-29(35)22-11-9-21(10-12-22)28(20-5-1-2-6-20)36-25-15-13-24(14-16-25)32-19-23-7-3-4-8-26(23)31-32/h3-4,7-16,19-20,28H,1-2,5-6,17-18H2,(H,30,35)(H,33,34)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
103n/an/an/an/an/an/a7.4n/a



Pfizer Inc.

US Patent


Assay Description
The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.


US Patent US8507533 (2013)


BindingDB Entry DOI: 10.7270/Q23R0RGH
More data for this
Ligand-Target Pair